Skip to Main Content

Paper Details

Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer.
Clin Cancer Res
57
2019
CD4, CD8, KRAS, M2 macrophage phenotype, NR tumors, Rectal Cancer, TP53, immune infiltrate, patients, rectal adenocarcinoma tumors, rectal cancer, tumor
Author NameAffiliation
Jochen K LennerzCenter for Integrated Diagnostics, Massachusetts General Hospital
Stephanie A WankowiczBroad Institute of MIT and Harvard
Stephanie A WankowiczDana-Farber Cancer Institute, Harvard Medical School
Adam TracyBroad Institute of MIT and Harvard
Scott L CarterBroad Institute of MIT and Harvard
Scott L CarterJoint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital
Eliezer M Van AllenBroad Institute of MIT and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute, Harvard Medical School
Eliezer M Van AllenBroad Institute of MIT and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 10

Datasets

Release 1.2